Literature DB >> 70935

Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study.

G Laurberg.   

Abstract

A double-blind study with tranexamic acid (Cyklokapron) was carried out in 17 patients with chronic urticaria. All patients had slightly depressed C1-chronic esterase inhibitor value. No significant differences were found between TA and placebo treatment periods.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70935

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  4 in total

Review 1.  Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications.

Authors:  Massimo Cugno; Angelo V Marzano; Riccardo Asero; Alberto Tedeschi
Journal:  Intern Emerg Med       Date:  2009-12-01       Impact factor: 3.397

Review 2.  Future prospects for use of fibrinolysis inhibitors.

Authors:  M Verstraete
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 3.  Clinical application of inhibitors of fibrinolysis.

Authors:  M Verstraete
Journal:  Drugs       Date:  1985-03       Impact factor: 9.546

4.  Causal Relationship between D-Dimers and Disease Status in Chronic Spontaneous Urticaria and Adjuvant Effect of Oral Tranexamic Acid.

Authors:  Garima Dabas; Vishal Thakur; Anuradha Bishnoi; Davinder Parsad; Ashok Kumar; Muthu Sendhil Kumaran
Journal:  Indian Dermatol Online J       Date:  2021-08-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.